Comparative analysis of obstetric, perinatal, and neurodevelopmental outcomes following chorionic villus sampling and amniocentesis
- PMID: 39005648
- PMCID: PMC11239381
- DOI: 10.3389/fmed.2024.1407710
Comparative analysis of obstetric, perinatal, and neurodevelopmental outcomes following chorionic villus sampling and amniocentesis
Abstract
Background: The risks of invasive prenatal tests are reported in previous studies such as miscarriage, fetal anomalies, and bleeding. However, few compare short-term and long-term outcomes between invasive tests. This study aims to investigate obstetric, perinatal, and children's neurodevelopmental outcomes following chorionic villus sampling (CVS) or amniocentesis in singleton pregnancy.
Methods: This retrospective cohort study included healthy singleton pregnancies underwent transabdominal CVS (gestational age [GA] at 10-13 weeks) or amniocentesis (GA at 15-21 weeks) at a single medical center between 2012 and 2022. Only cases with normal genetic results were eligible. Short-term and long-term neurodevelopmental outcomes were evaluated.
Results: The study included 200 CVS cases and 498 amniocentesis cases. No significant differences were found in body mass index, parities, previous preterm birth, conception method, and cervical length (CL) before an invasive test between the groups. Rates of preterm labor, preterm premature rupture of the membranes, preterm birth, neonatal survival, neonatal short-term morbidities, and long-term neurodevelopmental delay were similar. However, the CVS group had a higher rate of cervical cerclage due to short CL before 24 weeks (7.0%) compared to the amniocentesis group (2.4%). CVS markedly increased the risk of cervical cerclage due to short CL (adjusted odd ratio [aOR] = 3.17, 95%CI [1.23-8.12], p = 0.016), after considering maternal characteristics.
Conclusion: Performing CVS resulted in a higher incidence of cerclage due to short cervix or cervical dilatation compared to amniocentesis in singleton pregnancies. This highlights the importance of cautious selection for CVS and the necessity of informing women about the associated risks beforehand.
Keywords: CVS; amniocentesis; cerclage; cervical length; chorionic villus sampling; neurodevelopmental outcome.
Copyright © 2024 Kim, Joo, Kim, Kim, Ahn, Jung, Ryu and Lee.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study.Ultrasound Obstet Gynecol. 2017 May;49(5):599-606. doi: 10.1002/uog.15986. Ultrasound Obstet Gynecol. 2017. PMID: 27255564
-
Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis.Ultrasound Obstet Gynecol. 2019 Oct;54(4):452-457. doi: 10.1002/uog.20293. Epub 2019 Sep 6. Ultrasound Obstet Gynecol. 2019. PMID: 30977213
-
Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study.J Formos Med Assoc. 2019 Jul;118(7):1107-1113. doi: 10.1016/j.jfma.2019.03.006. Epub 2019 Mar 27. J Formos Med Assoc. 2019. PMID: 30928186
-
Risk of fetal loss following amniocentesis or chorionic villus sampling in twin pregnancy: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2020 Nov;56(5):647-655. doi: 10.1002/uog.22143. Epub 2020 Oct 13. Ultrasound Obstet Gynecol. 2020. PMID: 32632979
-
Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.Ultrasound Obstet Gynecol. 2019 Oct;54(4):442-451. doi: 10.1002/uog.20353. Epub 2019 Sep 6. Ultrasound Obstet Gynecol. 2019. PMID: 31124209
Cited by
-
Determinants of quality antenatal care use in Kenya: Insights from the 2022 Kenya Demographic and Health Survey.PLOS Glob Public Health. 2024 Sep 19;4(9):e0003460. doi: 10.1371/journal.pgph.0003460. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39298387 Free PMC article.
References
-
- Lee JY, Kwon JY, Na S, Choe SA, Seol HJ, Kim M, et al. . Clinical practice guidelines for prenatal aneuploidy screening and diagnostic testing from Korean society of maternal-fetal medicine: (2) invasive diagnostic testing for fetal chromosomal abnormalities. J Korean Med Sci. (2021) 36:e27. doi: 10.3346/jkms.2021.36.e26 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources